Researcher in Laboratory © HIPS

Sarah Frisch


After a bachelor’s degree in Applied Life Sciences Sarah Frisch studied Biotechnology at the UdS in Saarbrücken. Since 2020, she is a PhD student at the department of Drug Delivery (DDEL) at HIPS under Prof. Dr. Claus-Michael Lehr. She is part of the HIPS-UdS-TANDEM project and works on an in vitro model of the skin microbiome in destructive diseases of the hair follicle.


Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties

Huck B, Murgia X, Frisch S, Hittinger M, Hidalgo A, Loretz B, Lehr C (2022)

Advanced Drug Delivery Reviews 183DOI: 10.1016/j.addr.2022.114141


A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms

Frisch S, Boese A, Huck B, Horstmann J, Ho D, Schwarzkopf K, Murgia X, Loretz B, Souza Carvalho-Wodarz C, Lehr C (2021)

The Journal of antimicrobial chemotherapy 76 (6): 1472-1479DOI: 10.1093/jac/dkab068


Synthesis and Biopharmaceutical Characterization of Amphiphilic Squalenyl Derivative Based Versatile Drug Delivery Platform

Ho D, Christmann R, Murgia X, Rossi C, Frisch S, Koch M, Schaefer U, Loretz B, Desmaele D, Couvreur P, Lehr C (2020)

Frontiers in chemistry 8DOI: 10.3389/fchem.2020.584242


Farnesylated Glycol Chitosan as a Platform for Drug Delivery

Ho D, Frisch S, Biehl A, Terriac E, Rossi C, Schwarzkopf K, Lautenschläger F, Loretz B, Murgia X, Lehr C (2018)

Biomacromolecules 19 (8): 3489-3501DOI: 10.1021/acs.biomac.8b00795